Paying users zone. Data is covered by 
.
Get to Gilead Sciences Inc. for $17.99, or
get to entire website for at least 3 months from $49.99.
Analysis of Debt
Difficulty: Advanced
Total Debt (Carrying Amount)
Gilead Sciences Inc., Statement of Financial Position, Debt
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| Current portion of long-term debt, net | |
|
|
|
|
|
| Long-term debt, net, excluding current portion | |
|
|
|
|
|
| Total long-term debt (carrying amount) | |
|
|
|
|
Based on: 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25).
| Item | Description | The company |
|---|---|---|
| Total long-term debt (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Gilead Sciences Inc.’s total debt increased from 2015 to 2016 and from 2016 to 2017. |
Total Debt (Fair Value)
| Dec 31, 2017 | |
|---|---|
| Selected Financial Data (USD $ in millions) | |
| Total long-term debt (fair value) | |
| Ratio | |
| Debt, fair value to carrying amount | |
Based on: 10-K (filing date: 2018-02-27).
Weighted-average Interest Rate on Debt
Weighted-average effective interest rate on debt:
| Interest Rate | Debt Amount1 | Interest Rate × Debt Amount | Weighted-average Interest Rate2 | |
|---|---|---|---|---|
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
| Total | |
|
|
Based on: 10-K (filing date: 2018-02-27).
1 USD $ in millions
2 Weighted-average interest rate = 100 × ÷ =
